Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

被引：0
|
作者：
Barbara Fischer
Andreas Serra
Harry Telser
机构：
[1] Polynomics,Department of Internal Medicine and Nephrology
[2] Klinik Hirslanden,Center for Health, Policy and Economics
[3] University of Lucerne,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Chronic kidney disease; Hyperkalemia; Patiromer; Potassium binder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2717 / 2730
页数：13
相关论文
共 50 条
  • [41] Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia
    Hsu, Ta-Wei
    Liu, Jia-Sin
    Hung, Szu-Chun
    Kuo, Ko-Lin
    Chang, Yu-Kang
    Chen, Yu-Chi
    Hsu, Chih-Cheng
    Tarng, Der-Cherng
    JAMA INTERNAL MEDICINE, 2014, 174 (03) : 347 - 354
  • [42] "Renalism" with Renin Angiotensin Aldosterone System Inhibitor Use in Patients Enrolled in Trials for Heart Failure with Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Systematic Review
    Al Sudani, Hussein
    Shah, Samir
    Lo, Kevin Bryan
    Essa, Hani
    Wattoo, Ammaar
    Angelim, Lucas
    Brousas, Sophia
    Whybrow-Huppatz, Isabel
    Vellanki, Shaitalya
    Sankaranarayanan, Rajiv
    Rangaswami, Janani
    CURRENT VASCULAR PHARMACOLOGY, 2023, 21 (02) : 106 - 110
  • [43] COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB VERSUS BYPASSING AGENTS IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Souza, P.
    Puopolo, G. R.
    Leme-Souza, R.
    VALUE IN HEALTH, 2019, 22 : S847 - S847
  • [44] Effect of Renin-Angiotensin-Aldosterone System Blockade Therapy on Incidence of Contrast-induced Nephropathy in Patients with Chronic Kidney Disease
    Spatz, Christin
    Saadulla, Lawand
    Lapsiwala, Apurva
    Parhizgar, Amin
    Ghahramani, Nasrollah
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2012, 6 (06) : 432 - 436
  • [45] Changes in Serum and Urinary Potassium Handling Associated with Renin-Angiotensin-Aldosterone System Inhibitors in Advanced Chronic Kidney Disease Patients
    Ueda, Yuichiro
    Ookawara, Susumu
    Miyazawa, Haruhisa
    Ito, Kiyonori
    Hirai, Keiji
    Hoshino, Taro
    Morishita, Yoshiyuki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [46] Systematic Review and Meta-Analysis of Renin-Angiotensin-Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
    Yanai, Katsunori
    Ishibashi, Kenichi
    Morishita, Yoshiyuki
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
    Huang Rong-Shuang
    Cheng Yi-Ming
    Zeng Xiao-Xi
    Kim Sehee
    Fu Ping
    中华医学杂志英文版, 2016, 129 (05) : 562 - 569
  • [48] Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
    Huang, Rong-Shuang
    Cheng, Yi-Ming
    Zeng, Xiao-Xi
    Kim, Sehee
    Fu, Ping
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 562 - 569
  • [49] A systematic review and meta-analysis of the clinical impact of stopping renin–angiotensin system inhibitor in patients with chronic kidney disease
    Takashin Nakayama
    Ryunosuke Mitsuno
    Tatsuhiko Azegami
    Yasunori Sato
    Kaori Hayashi
    Hiroshi Itoh
    Hypertension Research, 2023, 46 : 1525 - 1535
  • [50] Renin-angiotensin-aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial
    Garcia-Prieto, A. M.
    Verdalles, U.
    de Jose, A. P.
    Arroyo, D.
    Aragoncillo, I.
    Barbieri, D.
    Camacho, R. E.
    Goicoechea, M.
    HIPERTENSION Y RIESGO VASCULAR, 2024, 41 (02): : 95 - 103
12345